OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Multiple strategies are employed maximize antibody titer, such as process parameter optimization, media optimization, and adoption of perfusion systems. Fine-tuning growth parameters plays a